Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-025-02511-7, published online 22 January 2025
In this article the Funding note “This work was partly supported by the National Key Research and Development Program of China (No. 2023YFC2508905 & 2022YFA1103300), the National Natural Science Foundation of China (82470214&82270227& 82070189), the Key Program of the National Natural Science Foundation of China (No. 81930004), Major Program of the National Natural Science Foundation of China (No. 82293630), Peking University Medicine Fund for world’s leading discipline or discipline cluster development (No.71003Y3035)” should be read “This work was partly supported by the Beijing Research Ward Excellence Program(BRWEP2024W134080102), the National Key Research and Development Program of China (No. 2023YFC2508905 & 2022YFA1103300), the National Natural Science Foundation of China (82470214&82270227& 82070189), the Key Program of the National Natural Science Foundation of China (No. 81930004), Major Program of the National Natural Science Foundation of China (No. 82293630), Peking University Medicine Fund for world’s leading discipline or discipline cluster development (No. 71003Y3035).”
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhou, C., Xu, L., Zhang, X. et al. Correction: Impact of TP53 alteration on allogeneic hematopoietic cell transplantation outcomes for myelodysplastic syndromes. Bone Marrow Transplant 60, 558 (2025). https://doi.org/10.1038/s41409-025-02526-0
Published:
Issue date:
DOI: https://doi.org/10.1038/s41409-025-02526-0
